Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis.

Pierre Le GuenSylvie ChevretEmmanuelle BugnetConstance de Margerie-MellonGwenaël LorillonAgathe Seguin-GiveletFanélie JouenneDominique GossotRobert VassalloAbdellatif Tazi

Published in: Orphanet journal of rare diseases (2019)

Our results show that pneumothorax recurrences occur during an "active" phase of PLCH. In this observational study, the time of occurrence of the first ipsilateral recurrence and the overall number of pneumothorax recurrences were similar after conservative and thoracic surgical treatments. Further studies are needed to determine the best management to reduce the risk of pneumothorax recurrence in PLCH patients.

Keyphrases

end stage renal disease
ejection fraction
risk assessment
spinal cord
single cell
cell therapy
stem cells
metabolic syndrome
patient reported outcomes
mesenchymal stem cells
bone marrow
patient reported
weight loss